<--- Back to Details
First PageDocument Content
National Institutes of Health / Hematopathology / Sickle-cell disease / Hydroxycarbamide / Fetal hemoglobin / Consensus / National Institute of Diabetes and Digestive and Kidney Diseases / Clinical trial / Sickle cell trait / Medicine / Health / Nursing research
Date: 2013-09-27 09:05:18
National Institutes of Health
Hematopathology
Sickle-cell disease
Hydroxycarbamide
Fetal hemoglobin
Consensus
National Institute of Diabetes and Digestive and Kidney Diseases
Clinical trial
Sickle cell trait
Medicine
Health
Nursing research

The Laboratory Evidence of Efficacy of Hydroxyurea in the

Add to Reading List

Source URL: consensus.nih.gov

Download Document from Source Website

File Size: 928,71 KB

Share Document on Facebook

Similar Documents

Cell Biology and Cancer under a contract from the National Institutes of Health in collaboration with the National Cancer Institute

DocID: 1vqc4 - View Document

SCIENCE & TECHNOLOGY POLICY IN STITUTE Technology Development at the National Institutes of Health (NIH): Summary Report Brian L. Zuckerman

DocID: 1v9kv - View Document

DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Heart, Lung, and Blood Institute (NHLBI)

DocID: 1v3b2 - View Document

Conference Organizers James Prestegard, CFG and University of Georgia Michael Tiemeyer, CFG and University of Georgia John Hanover, CFG and National Institutes of Health Joyce Taylor-Papadimitriou, CFG and King’s Colle

DocID: 1v07l - View Document

Nematode sperm motility* Harold E. Smith§ National Institute for Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda MD, USA Table of Contents

DocID: 1uVU8 - View Document